Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans
Shanshan Zhang(Tianjin University), Xin Chen(University of California, San Francisco)
Cited by 36
Related Papers
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver
|Oncotarget|2015|68
MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research
|BMC Cancer|2019|52
Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway
|Experimental & Molecular Medicine|2018|50
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade
|PLoS ONE|2017|42
Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes
|International Journal of Oncology|2015|39